Tuesday, 10 Dec 2019

You are here

The RheumNow Week in Review – 11 August 2017

The RheumNow Week in Review caps the week's news every Friday. Dr Jack Cush reviews the news, journal reports and important events from the past week in rheumatology.  This week's news highlights include new data on the incidence of arthritis, lag times in patient referral, criteria for referral and why/how weather change affects arthritis pain.

  1. Finland RA Incidence 41/100k; SpA 36/100K; ReA 8/100k; undiff arthritis 39/100K. P gingivalis assoc w/ ACPA, men https://t.co/cGyc9mMaIF
  2. RA Lag times from Sx to 1st DMARD 11.8mo; 1st Sx to 1st MD 3.1 mo; MD to Rheum referral 2.1 mo; Rheum to Dx 2.9 mo https://t.co/j2HHSTrcgY
  3. Anti-TIF1-gamma Ab assoc cancer w/ myositis (78% sens; 89% specificity), but rarely w/ cancer, paraneoplastic syndr. https://t.co/Yd1O2MVVG1
  4. "Prednisone is the best drug we have, and prednisone is the worst drug we have"- Peter A. Merkel, MD
  5. The Vast majority of patients w/ chronic hepatitis C can safely receive etanercept and other TNFi https://t.co/8ER67gRQHA
  6. Tanezumab (MAb against nerve growth factor) is being fast-tracked by FDA as a non-opioid pain reliever. https://t.co/ZXJnS7CmE4
  7. Good review of Scleroderma & PSS ILD. 5 Yr mortality of PSS+ILD is 82–90%. https://t.co/UR8oADk6E3
  8. Doctors shouldnt do TEXT medicine OR Email medicine; these are incomplete, chancy, convenient but inaccurate- Phone medicine not much better
  9. Joint Pain Linked to Increasing Temperature, Not Rainfall 
  10. Criteria for Early Referrals from Primary Care
  11. MSK Ultrasound Now Standard for Rheumatology Training

 

Disclosures: 
The author has received compensation as an advisor or consultant on this subject

Rheumatologists' Comments

I have had a chance to observe the use of US by my younger colleagues who are very adept with the technology while I have been doing in locums work. I would say that US can help reduce diagnostic uncertainty in regards to inflammatory arthritis including “undifferentiated arthritis”, crystal-induced arthritis, unexpected anatomy or pathology and challenging aspirations and injections of joints and soft tissue structures (carpal tunnel, tendons, bursa, etc). US is an additional tool that decreases uncertainty in a timely manner. While not a “game-changer”, US appears to be a very useful tool with both diagnostic and therapeutic applications that make our lives a little bit easier. It’s also fun to do with immediate gratification!

More Like This

RheumNow Podcast - Monitoring Methotrexate Safety (12-6-19)

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.

#WomenInRheumatology: Is There a Speaker Gender Gap at ACR Meetings?

Recent studies have quantified the gender gap among speakers at academic conferences. The largest study of 181 medical conferences held in North America over one decade found an increase in the proportion of female speakers from 25 to 34% over time, and that the underrepresentation of women was more marked at surgical compared to medical conferences.

RheumNow Podcast –Favorites of ACR 2019 (11.22.19)

Dr. Jack Cush recaps standout presentations and information from ACR 2019 held in Atlanta November 9-12, 2019.

Hepatitis C-Related Cryoglobulinemic Vasculitis

Flares of vasculitis can still be a problem after hepatitis C-related cryoglobulinemic vasculitis patients are cured of their hepatitis C by direct-acting antivirals, as demonstrated by data from four registries presented at ACR 2019 in Atlanta, Georgia.

ACR 2019 - Report from Day One (Sunday)

Sunday was the first full day of scientific sessions at the 2019 ACR/ARP meeting in Atlanta. Yesterday we shared our initial news articles, videos and more with you. Following is my roundup of day one. 

Delays in Diagnosis